Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ROSUVASTATIN vs ROXITHROMYCIN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

ROSUVASTATIN vs ROXITHROMYCIN: Safety Overview

Metric ROSUVASTATIN ROXITHROMYCIN
Total FAERS Reports 36,332 352
Deaths Reported 1,536 43
Death Rate 4.2% 12.2%
Hospitalizations 11,195 189
Average Patient Age 66.1 yrs 57.9 yrs
% Female Patients 54.9% 57.9%
FDA Approval Date Apr 1, 2020 N/A
Manufacturer Umedica Laboratories USA Inc. N/A
Route ORAL N/A
Marketing Status Prescription N/A